Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 45, 2021 - Issue 6
128
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Profiling of 35 Cases of Hb S/Hb E (HBB: c.20A>T/HBB: c.79G>a), Disease and Association with α-Thalassemia and β-Globin Gene Cluster Haplotypes from Odisha, India

ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon, & show all
Pages 380-386 | Received 30 Apr 2021, Accepted 22 Jul 2021, Published online: 04 Mar 2022

References

  • Colah RB, Mukherjee MB, Martin S, et al. Sickle cell disease in tribal populations in India. Indian J Med Res. 2015;141(5):509–515.
  • Mohanty D, Mukherjee MB. Sickle cell disease in India. Curr Opin Hematol. 2002;9(2):117–122.
  • Balgir RS. Aberrant heterosis in hemoglobinopathies with special reference to thalassemia and structurally abnormal hemoglobins E and S in Orissa, India. J Clin Diagn Res. 2007;1(3):122–130.
  • Greer JP, Foerster J, Lukens JN, et al., Editors. Abnormal hemoglobins: general considerations. Wintrobe's Clinical Hematology, 11th ed. Philadelphia (PA): Lippincott Williams & Wilkins. 2004:1247–1262.
  • Aksoy M, Lehmann H. The first observation of sickle-cell haemoglobin E disease. Nature. 1957;179(4572):1248–1249.
  • Mukhopadhyay S, Kumar N, Saxena R. Sickle cell-hemoglobin E disease in an Indian family. Indian J Pathol Microbiol. 2001;44(4):465–466.
  • Weatherall DJ, Clegg JB. Distribution and population genetics of the thalassaemias. In: Gibbons R, Higgs DR, Old JM, Editors. The Thalassaemia Syndromes, 4th ed. Oxford (Oxon, UK): Blackwell Science. 2001:241–246.
  • Balgir RS. Genetic epidemiology of the three predominant abnormal hemoglobins in India. J Assoc Phys India. 1996;44(1):25–28.
  • Balgir RS. Emerging trends in genetic epidemiology of haemoglobinopathies in Seven Sister States of North Eastern India. In: Das RJ, Basu D, Editors. Anthropological Perspectives: North East India. New Delhi (India): Akansha Publishing House. 2003:17–37.
  • Mohanty D, Colah RB, Gorakshakar AC, et al. Prevalence of β-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study. J Community Genet. 2013;4(1):33–42.
  • Ambekar SS, Phadke MA, Mokashi GD, et al. Pattern of hemoglobinopathies in Western Maharashtra. Indian Pediatr. 2001;38(5):530–534.
  • Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual, 3rd ed. Cold Spring Harbor (NY, USA): Cold Spring Harbor Laboratory, 2001.
  • Dehury S, Meher S, Patel S, et al. Compound heterozygote of Hb S (HBB: c.20A>T)/Hb Westdale (HBB: c.380_396delTGCAGGCTGCCTATCAG): report of four cases from Odisha State, India. Hemoglobin. 2019;43(2):132–136.
  • Chong SS, Boehm CD, Higgs DR, et al. Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood. 2000;95(1):360–362.
  • Sutton M, Bouhassira EE, Nagel RL. Polymerase chain reaction amplification applied to the determination of beta-like globin gene cluster haplotypes. Am J Hematol. 1989;32(1):66–69.
  • Patel DK, Mashon RS, Patel S, et al. β-Globin gene haplotypes linked with the Hb D-Punjab [β121(GH4)Glu→Gln, GAA>CAA] mutation in Eastern India. Hemoglobin. 2010;34(6):530–537.
  • Dash PM, Sahu PK, Patel S, et al. Effect of assorted globin haplotypes and α-thalassemia on the clinical heterogeneity of Hb S-β-thalassemia. Hemoglobin. 2018;42(4):236–242.
  • Srinivas R, Dunda O, Krishnamoorthy R, et al. Atypical haplotypes linked to the beta S gene in Africa are likely to be the product of recombination. Am J Hematol. 1988;29(1):60–66.
  • Aksoy M. The hemoglobin E syndromes. II. Sickle cell-hemoglobin E disease. Blood. 1960;15(5):610–613.
  • Altay C, Niazi GA, Huisman THJ. The combination of HB S and HB E in a black female. Hemoglobin. 1976–1977;1(1):100–110.
  • Schroeder WA, Powars D, Reynolds RD, et al. Hb-E in combination with Hb-S and Hb-C in a black family. Hemoglobin. 1977;1(3):287–289.
  • Engelstad BL. Functional asplenia in hemoglobin SE disease. Clin Nucl Med. 1982;7(3):100–102.
  • Hardy MJ, Ragbeer MS. Homozygous HbE and HbSE disease in a Saudi family. Hemoglobin. 1985;9(1):47–52.
  • Ramahi AJ, Lewkow LM, Dombrowski MP, et al. Sickle cell E hemoglobinopathy and pregnancy. Obstet Gynecol. 1988;71(3 Pt 2):493–495.
  • Rey KS, Unger CA, Rao SP, et al. Sickle cell-hemoglobin E disease: clinical findings and implications. J Pediatr. 1991;119(6):949–951.
  • Gupta R, Jarvis M, Yardumian A. Compound heterozygosity for haemoglobin S and haemoglobin E. Br J Haematol. 2000; 108(3):463.
  • Knox-Macaulay HHM, Ahmed MM, Gravell D, et al. Sickle cell-haemoglobin E (HbSE) compound heterozygosity: a clinical and haematological study. Int J Lab Hematol. 2007;29(4):292–301.
  • Vishwanathan C, Agarwal MB, Bichille LS, et al. Double heterozygosity for hemoglobin S and E. Indian Pediatr. 1992;29(7):895–897.
  • Italia K, Upadhye D, Dabke P, et al. Clinical and hematological presentation among Indian patients with common hemoglobin variants. Clin Chim Acta. 2014;431:46–51.
  • Sahu P, Purohit P, Mantri S, et al. Spectrum of hemoglobin disorders in southern Odisha, India: a hospital based study. Porto Biomed J. 2021;6(1):e126.
  • Dani AA, Shrikhande AV. Double heterozygous for hemoglobin S and hemoglobin E – a case report from central India. Indian J Hematol Blood Transfus. 2007;23(3–4):119–121.
  • Eichhorn RF, Buurke EJ, Blok P, et al. Sickle cell-like crisis and bone marrow necrosis associated with parvovirus B19 infection and heterozygosity for haemoglobins S and E. J Intern Med. 1999;245(1):103–106.
  • Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018–2031.
  • Quinn CT. Minireview: clinical severity in sickle cell disease: the challenges of definition and prognostication. Exp Biol Med. 2016;241(7):679–688.
  • Eaton WA, Bunn HF. Treating sickle cell disease by targeting HbS polymerization. Blood. 2017;129(20):2719–2726.
  • Amato A, Cappabianca MP, Perri M, et al. Interpreting elevated fetal hemoglobin in pathology and health at the basic laboratory level: new and known γ- gene mutations associated with hereditary persistence of fetal hemoglobin. Int J Lab Hematol. 2014;36(1):13–19.
  • Masiello D, Heeney MM, Adewoye AH, et al. Hemoglobin SE disease: a concise review. Am J Hematol. 2007;82(7):643–649.
  • Alkindi SS, AlZadjali S, Daar S, et al. A stepwise α-thalassemia screening strategy in high-prevalence areas. Eur J Haematol. 2013;91(2):164–169.
  • Stevens MC, Maude GH, Beckford M, et al. Alpha thalassemia and the hematology of homozygous sickle cell disease in childhood. Blood. 1986;67(2):411–414.
  • Higgs DR, Aldridge BE, Lamb J, et al. The interaction of alpha-thalassemia and homozygous sickle-cell disease. N Engl J Med. 1982;306(24):1441–1446.
  • Thein SL. Genetic modifiers of the beta-haemoglobinopathies. Br J Haematol. 2008;141(3):357–366.
  • Patel DK, Purohit P, Dehury S, et al. Fetal hemoglobin and alpha thalassemia modulate the phenotypic expression of HbSD-Punjab. Int J Lab Hematol. 2014;36(4):444–450.
  • Purohit P, Dehury S, Patel S, et al. Prevalence of deletional alpha thalassemia and sickle gene in a tribal dominated malaria endemic area of eastern India. ISRN Hematol. 2014;2014:745245.
  • Mukherjee MB, Surve RR, Gangakhedkar RR, et al. β-Globin gene cluster haplotypes linked to the βS gene in western India. Hemoglobin. 2004;28(2):157–161.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.